REGULATION OF C-MYB EXPRESSION IN ML-1 HUMAN MYELOBLASTIC-LEUKEMIA CELLS BY C-ETS-1 PROTEIN

被引:7
作者
BLOCH, A
LIU, XM
WANG, LG
机构
[1] Department of Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo
来源
ADVANCES IN ENZYME REGULATION, VOL 35 | 1995年 / 35卷
关键词
D O I
10.1016/0065-2571(94)00019-Y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C-myb and c-ets-1 have variously been demonstrated to function as protooncogenes. Using a human leukemic cell line, ML-1, we have examined the mechanism by which these genes participate in establishing the sustained proliferation mode that is characteristic of the transformed cell. In the absence of serum, ML-1 cells were found to require IGF-1 and transferrin (TF) for growth and TGF-β or TNF-α plus TF for differentiation. Upon administration of the growth factors, c-myb expression increased within 60 min, whereas after addition of the differentiation factors c-myb expression ceased completely within 3 hr. A correlation was found to exist between the level of c-ets-1 protein in the cells, the extent to which that protein is bound to intron I of the myb gene and the amount of c-myb mRNA that is expressed. Upon administration of growth factors, a sizable increase in the intracellular, and particularly, in the intranuclear level of c-ets-1 protein was observed, whereas a pronounced decrease in the level of this protein occurred after exposure to the differentiation factors. These data demonstrated that the level at which an oncogene-specified transcription factor is expressed can affect the expression of other target oncogenes involved in the regulation of cell proliferation. Stimulated expression of such transcription factor can then lead to the continuous proliferation cycle characteristic of the cancer cell. © 1995.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 21 条
[1]   DIFFERENTIAL EXPRESSION OF C-MYB MESSENGER-RNA IN MURINE-B LYMPHOMAS BY A BLOCK TO TRANSCRIPTION ELONGATION [J].
BENDER, TP ;
THOMPSON, CB ;
KUEHL, WM .
SCIENCE, 1987, 237 (4821) :1473-1476
[2]  
BLOCH A, 1993, LEUKEMIA, V7, P1219
[3]   FUNCTIONAL-SIGNIFICANCE OF C-MYB EXPRESSION IN NORMAL AND LEUKEMIC HEMATOPOIESIS [J].
CALABRETTA, B ;
VENTURELLI, D ;
GEWIRTZ, AM .
CANCER INVESTIGATION, 1993, 11 (02) :191-197
[4]  
CHEN JH, 1990, ONCOGENE RES, V5, P277
[5]  
CHEN TM, 1992, ONCOGENE, V7, P1541
[6]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[7]  
CRAIG RW, 1984, CANCER RES, V44, P442
[8]  
DENSTMAN S, 1991, J BIOL CHEM, V266, P14873
[9]   A SINGLE POINT MUTATION IN THE V-ETS ONCOGENE AFFECTS BOTH ERYTHROID AND MYELOMONOCYTIC CELL-DIFFERENTIATION [J].
GOLAY, J ;
INTRONA, M ;
GRAF, T .
CELL, 1988, 55 (06) :1147-1158
[10]   USE OF A PROTEIN-BLOTTING PROCEDURE AND A SPECIFIC DNA PROBE TO IDENTIFY NUCLEAR PROTEINS THAT RECOGNIZE THE PROMOTER REGION OF THE TRANSFERRIN RECEPTOR GENE [J].
MISKIMINS, WK ;
ROBERTS, MP ;
MCCLELLAND, A ;
RUDDLE, FH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (20) :6741-6744